Search

Fungal infections and antifungal resistance are a significant problem; here’s one approach to consider

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.

How can companies beat the bottlenecks in viral vector manufacturing?

US-based law and patenting experts offer their thoughts on IP protection in the digital age

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

I explore recent cases of pediatric cough medicines contaminated with diethylene glycol.

The EMA is reviewing whether certain Novo Nordisk drugs are linked to suicidal thoughts

Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price.

With the right technology in place, manufacturers can avoid the supply shortfalls experienced during respiratory season